Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of sequential IL-2 then pegylated interferon in HCV-associated systemic vasculitis resistant to conventional treatment
2006-004039-31Phase 2Completed
- Sponsor
- ANRS
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aldesleukin and pegylated interferon alpha in hepatitis C virus infection and Viral vasculitis, sponsored by ANRS. Started Apr 2007; status: completed.
02
Drugs
aldesleukinpegylated interferon alpha
03
Conditions
hepatitis C virus infectionViral vasculitis
Beyond the preview
Go deeper on 2006-004039-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004039-31.